5-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells
- PMID: 36142724
- PMCID: PMC9503420
- DOI: 10.3390/ijms231810812
5-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells
Abstract
Multidrug resistance (MDR) is considered one of the major mechanisms responsible for the failure of numerous anticancer and antiviral chemotherapies. Various strategies to overcome the MDR phenomenon have been developed, and one of the most attractive research directions is focused on the inhibition of MDR transporters, membrane proteins that extrude cytotoxic drugs from living cells. Here, we report the results of our studies on a series newly synthesized of 5-arylidenerhodanines and their ability to inhibit the ABCB1 efflux pump in mouse T-lymphoma cancer cells. In the series, compounds possessing a triphenylamine moiety and the carboxyl group in their structure were of particular interest. These amphiphilic compounds showed over 17-fold stronger efflux pump inhibitory effects than verapamil. The cytotoxic and antiproliferative effects of target rhodanines on T-lymphoma cells were also investigated. A putative binding mode for 11, one of the most potent P-gp inhibitors tested here, was predicted by molecular docking studies and discussed with regard to the binding mode of verapamil.
Keywords: P-glycoprotein; T-lymphoma cancer cells; cancer multidrug resistance; crystal structure; efflux pump inhibition; molecular docking; rhodanine.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.Molecules. 2020 May 11;25(9):2258. doi: 10.3390/molecules25092258. Molecules. 2020. PMID: 32403277 Free PMC article.
-
Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.Eur J Med Chem. 2020 Aug 15;200:112435. doi: 10.1016/j.ejmech.2020.112435. Epub 2020 May 15. Eur J Med Chem. 2020. PMID: 32505850
-
An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.Bioorg Chem. 2021 Apr;109:104735. doi: 10.1016/j.bioorg.2021.104735. Epub 2021 Feb 18. Bioorg Chem. 2021. PMID: 33640632
-
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.Drug Resist Updat. 2020 May;50:100682. doi: 10.1016/j.drup.2020.100682. Epub 2020 Feb 7. Drug Resist Updat. 2020. PMID: 32087558
-
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update.Eur J Med Chem. 2022 Sep 5;239:114542. doi: 10.1016/j.ejmech.2022.114542. Epub 2022 Jun 17. Eur J Med Chem. 2022. PMID: 35751979 Review.
Cited by
-
Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1).Int J Mol Sci. 2023 Mar 10;24(6):5298. doi: 10.3390/ijms24065298. Int J Mol Sci. 2023. PMID: 36982374 Free PMC article.
-
Molecular Modeling Studies to Probe the Binding Hypothesis of Novel Lead Compounds against Multidrug Resistance Protein ABCB1.Biomolecules. 2024 Jan 16;14(1):114. doi: 10.3390/biom14010114. Biomolecules. 2024. PMID: 38254714 Free PMC article.
-
Recent Advances on P-Glycoprotein (ABCB1) Transporter Modelling with In Silico Methods.Int J Mol Sci. 2022 Nov 26;23(23):14804. doi: 10.3390/ijms232314804. Int J Mol Sci. 2022. PMID: 36499131 Free PMC article. Review.
References
-
- Park S.H., Park C.J., Kim D.Y., Lee B.R., Kim Y.J., Cho Y.U., Jang S. MRP1 and P-glycoprotein expression assays would be useful in the additional detection of treatment non-responders in CML patients without ABL1 mutation. Leuk. Res. 2015;39:1109–1116. doi: 10.1016/j.leukres.2015.07.006. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous